CT-guided radioactive 125I seeds brachytherapy for lung oligometastases from colorectal cancer: initial results
- PMID: 38403626
- PMCID: PMC10895717
- DOI: 10.1186/s12885-024-12013-2
CT-guided radioactive 125I seeds brachytherapy for lung oligometastases from colorectal cancer: initial results
Abstract
Objectives: To evaluate the safety and effectiveness of computed tomography (CT)-guided radioactive 125I seeds brachytherapy (RISB) for lung oligometastases (LO) from colorectal cancer (CRC).
Methods: Data for 144 LOs from 70 CRC patients who underwent CT-guided RISB were retrospectively analyzed. The primary endpoints were progression-free survival (PFS) and overall survival (OS), and the secondary endpoints were technical success, local control rate (LCR), and complications. Kaplan-Meier method was used for survival analysis. Cox model was used to identify the independent predictors of poor prognosis.
Results: The RISB procedures were successfully performed in all patients, and the success rate was 100%. The median follow-up was 27.8 months. The median PFS was 10.0 months (95% CI: 8.9-11.1) and the 1- and 2-year PFS rates were 32.9% and 5.9%, respectively. On multivariate analysis, serum carcinoembryonic antigen (CEA) ≤ 15 ng/ml (P = 0.048), middle-high differentiated pathological classification (P = 0.015), primary TNM stages I-III (P = 0.001), LO number ≤ 2 (P < 0.001) and cumulative gross tumor volume (GTV) ≤ 40 cm3 (P < 0.001) showed superior PFS. The median OS was 30.8 months (95% CI: 27.1-34.4) and the 1-, 2-, and 3-year OS rates were 95.7%, 67.4%, and 42.5%, respectively. On multivariate analysis, serum CEA ≤ 15 ng/ml (P = 0.004), middle-high differentiated pathological classification (P < 0.001), primary TNM stages I-III (P < 0.001), LO number ≤ 2 (P < 0.001), cumulative GTV ≤ 40 cm3 (P < 0.001) and system treatments combined with chemotherapy and target therapy (P < 0.001) showed superior OS. The LCR for 3, 6, and 12 months was 97.9%, 91.0%, and 83.6%, respectively. There were 4 cases of pneumothorax at 5.7% that required drainage.
Conclusions: RISB for LO from CRC is safe and effective, and serum CEA, TNM stage, LO number, cumulative GTV, and system treatments should be emphasized for long OS.
Keywords: 125I brachytherapy; Clinical study; Colorectal cancer; Lung oligometastases.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10895717/bin/12885_2024_12013_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10895717/bin/12885_2024_12013_Fig2_HTML.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10895717/bin/12885_2024_12013_Fig3_HTML.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10895717/bin/12885_2024_12013_Fig4_HTML.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10895717/bin/12885_2024_12013_Fig5_HTML.gif)
Similar articles
-
Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).Rofo. 2014 Jun;186(6):606-12. doi: 10.1055/s-0033-1355887. Epub 2014 Jan 9. Rofo. 2014. PMID: 24407711
-
The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer-A retrospective cohort study.Cancer Med. 2018 Nov;7(11):5327-5338. doi: 10.1002/cam4.1814. Epub 2018 Oct 9. Cancer Med. 2018. PMID: 30302946 Free PMC article.
-
[Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Apr 25;20(4):443-449. Zhonghua Wei Chang Wai Ke Za Zhi. 2017. PMID: 28440527 Chinese.
-
Feasibility and Clinical Value of CT-guided (125)I Brachytherapy for Bilateral Lung Recurrences from Colorectal Carcinoma.Radiology. 2016 Mar;278(3):897-905. doi: 10.1148/radiol.2015150641. Epub 2015 Sep 25. Radiology. 2016. PMID: 26406550 Clinical Trial.
-
Efficacy and safety of CT-guided high-dose-rate interstitial brachytherapy in primary and secondary malignancies of the pancreas.Eur J Radiol. 2019 Mar;112:22-27. doi: 10.1016/j.ejrad.2018.12.020. Epub 2018 Dec 28. Eur J Radiol. 2019. PMID: 30777214
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical